S'abonner

Exposure to welding fumes and lower airway infection with Streptococcus pneumoniae - 05/02/16

Doi : 10.1016/j.jaci.2015.06.033 
Reetika Suri, PhD a, Jimstan Periselneris, MB BS b, Sophie Lanone, PhD c, Patti C. Zeidler-Erdely, PhD d, Geoffrey Melton, BSc e, Keith T. Palmer, MD f, Pascal Andujar, MD c, James M. Antonini, PhD d, Vanessa Cohignac, MSc c, Aaron Erdely, PhD d, Ricardo J. Jose, MB BS b, Ian Mudway, PhD g, Jeremy Brown, MD b, Jonathan Grigg, MD a,
a Blizard Institute, Queen Mary University of London, London, United Kingdom 
b Centre for Inflammation and Tissue Repair, Department of Medicine, Royal Free and University College Medical School, Rayne Institute, London, United Kingdom 
c Inserm U955 Équipe 4, Faculté de Médecine, Créteil, France 
d Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 
e Welding Institute, Cambridge, United Kingdom 
f MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom 
g MRC-PHE Centre for Environment and Health, Analytical & Environmental Sciences Division, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom 

Corresponding author: Jonathan Grigg, MD, Blizard Institute, London E1 2AT, United Kingdom.

Abstract

Background

Welders are at increased risk of pneumococcal pneumonia. The mechanism for this association is not known. The capacity of pneumococci to adhere to and infect lower airway cells is mediated by host-expressed platelet-activating factor receptor (PAFR).

Objective

We sought to assess the effect of mild steel welding fumes (MS-WF) on PAFR-dependent pneumococcal adhesion and infection to human airway cells in vitro and on pneumococcal airway infection in a mouse model.

Methods

The oxidative potential of MS-WF was assessed by their capacity to reduce antioxidants in vitro. Pneumococcal adhesion and infection of A549, BEAS-2B, and primary human bronchial airway cells were assessed by means of quantitative bacterial culture and expressed as colony-forming units (CFU). After intranasal instillation of MS-WF, mice were infected with Streptococcus pneumoniae, and bronchoalveolar lavage fluid (BALF) and lung CFU values were determined. PAFR protein levels were assessed by using immunofluorescence and immunohistochemistry, and PAFR mRNA expression was assessed by using quantitative PCR. PAFR was blocked by CV-3988, and oxidative stress was attenuated by N-acetylcysteine.

Results

MS-WF exhibited high oxidative potential. In A549 and BEAS-2B cells MS-WF increased pneumococcal adhesion and infection and PAFR protein expression. Both CV-3988 and N-acetylcysteine reduced MS-WF–stimulated pneumococcal adhesion and infection of airway cells. MS-WF increased mouse lung PAFR mRNA expression and increased BALF and lung pneumococcal CFU values. In MS-WF–exposed mice CV-3988 reduced BALF CFU values.

Conclusions

Hypersusceptibility of welders to pneumococcal pneumonia is in part mediated by the capacity of welding fumes to increase PAFR-dependent pneumococcal adhesion and infection of lower airway cells.

Le texte complet de cet article est disponible en PDF.

Key words : Occupational disease, welding fumes, platelet-activating factor receptor, Streptococcus pneumoniae, pneumonia, bacterial adhesion and infection

Abbreviations used : BALF, CFU, IPD, LDH, MS-WF, NAC, OP, PAFR, PM, StS-WF, UK, WF


Plan


 Supported by Colt Foundation grant number CF/05/12. R.J.J. is supported by Wellcome Trust grant 097216/Z/11/Z, and J.P. is supported by Medical Research Council grant MR/K00168X/1.
 Disclosure of potential conflict of interest: G. Melton is exclusively funded by the Welding Institute (an independent research organization, limited by guarantee), which is funded by member subscriptions (about 800 members worldwide), single-client and joint industry projects, and European Union– and United Kingdom–funded projects. The rest of the authors declare that they have no relevant conflicts of interest.


© 2015  American Academy of Allergy, Asthma & Immunology. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 137 - N° 2

P. 527 - février 2016 Retour au numéro
Article précédent Article précédent
  • Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells
  • Anna-Sophia Wiekmeijer, Karin Pike-Overzet, Hanna IJspeert, Martijn H. Brugman, Ingrid L.M. Wolvers-Tettero, Arjan C. Lankester, Robbert G.M. Bredius, Jacques J.M. van Dongen, Willem E. Fibbe, Anton W. Langerak, Mirjam van der Burg, Frank J.T. Staal
| Article suivant Article suivant
  • Exchange protein directly activated by cyclic AMP (EPAC) activation reverses neutrophil dysfunction induced by ?2-agonists, corticosteroids, and critical illness
  • Jonathan Scott, Graham J. Harris, Emma M. Pinder, James G. Macfarlane, Thomas P. Hellyer, Anthony J. Rostron, Andrew Conway Morris, David R. Thickett, Gavin D. Perkins, Daniel F. McAuley, John D. Widdrington, Sarah Wiscombe, Simon V. Baudouin, Alistair I. Roy, Vanessa C. Linnett, Stephen E. Wright, Marie-Hélène Ruchaud-Sparagano, A. John Simpson

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.